An Evaluation of the Emerging Interventions Against Respiratory Syncytial Virus (RSV)-Associated Acute Lower Respiratory Infections in Children

This article, published in BMC Public Health, summarizes the results of a literature review and an expert opinion exercise to evaluate the best course of protection against respiratory syncytial virus (RSV) for children in the developing world, where most episodes occur. Results show that candidate vaccines for active immunization of infants against RSV hold the greatest promise. Further, introduction of a low-cost vaccine against RSV would reduce the inequitable distribution of burden due to childhood acute lower respiratory infections (ALRI) and will most likely have a high impact on morbidity and mortality due to severe ALRI.

Author(s): Nair H, Verma VR, Theodoratou E, et al.

Published: 2011

  • Visit web page (English)

    (Located at www.biomedcentral.com)

    Citation: Nair H, Verma VR, Theodoratou E, et al. An Evaluation of the Emerging Interventions Against Respiratory Syncytial Virus (RSV)-Associated Acute Lower Respiratory Infections in Children. BMC Public Health. 2011;11(S3):S30.